U.S. stocks bounced around in the green in far more stable trading following three days of extreme swings. Apple (AAPL) led the Dow Jones Industrial Average for its second day as confidence in the iPhone 7's preorder performance grew. Crude oil prices fluctuated after a weekly decline in crude inventories. The EIA reported a decline of 600,000 barrels in the past week, a welcome sign of diminishing supplies in the face of tepid demand. Herbalife (HLF) climbed after billionaire activist Carl Icahn disclosed he had asked the FTC to buy up to 50% of the company. Icahn already has permission to buy just over one-third. Biogen (BIIB) rose on positive clinical and real-world trials of its multiple sclerosis treatment. The drugmaker said the treatment "demonstrates strong efficacy" in reducing disease activity over time.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.